Early research (Phase 1)Active Not RecruitingNCT04958239
What this trial is testing
Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Who this might be right for
Neoplasms
Boehringer Ingelheim 151